Literature DB >> 35525856

Real-world treatment patterns and outcomes in Japanese patients with cervical esophageal cancer.

Kazuchika Ohno1, Motomi Nasu2, Hidetoshi Matsui3, Yoshifumi Baba4, Takushi Yasuda5, Jun Sakuma6, Kenichiro Ikeda7, Takashi Maruo8, Takumi Okuda9, Norihiko Narita10, Hisayuki Kato11, Taiji Kawasaki12, Hiroshi Sato13, Kunihiko Tokashiki14, Naoki Akisada15, Hajime Ishinaga16, Ken Akashi17, Kenji Okami18, Kosuke Murayama19, Soichiro Yamamoto20, Yuji Kumakura21, Kenro Kawada22, Akihiro Shiotani23,24, Takahiro Asakage25.   

Abstract

BACKGROUND: Cervical esophageal cancer (CEC) carries a poor prognosis; however, due to its low incidence, optimal treatment for CEC remains to be established. The purpose of this study was to clarify the current status of treatment of CEC in Japan and obtain evidence for establishing the appropriate treatment method. PATIENTS AND METHODS: We asked specialist training facilities accredited by the Japanese Broncho-Esophageal Society to register data on CEC cases that received curative treatment from January 2009 to December 2014, and conducted a retrospective review of the clinical data of 302 cases registered from 27 facilities.
RESULTS: In regard to the initial therapy, of the 302 patients, 33 had undergone endoscopic resection, 41 had undergone surgery, 67 had received induction chemotherapy (IC), and 143 had received chemoradiotherapy (CRT). There were no significant differences in the 5-year overall survival rates among the patient groups that had received surgery, IC or CRT as the initial treatment; advanced stage and recurrent nerve invasion were identified as independent poor prognostic factors. Among the patients who had received IC or CRT as laryngeal-preserving surgery was not indicated at the time of the initial diagnosis, the functional laryngeal preservation rate at the end of the observation period was 34.8%.
CONCLUSION: Even in patients with advanced CEC, there is the possibility of preserving the larynx by adopting IC or CRT. However, if the laryngeal function cannot be preserved, there is a risk of complications from aspiration pneumonia, so that the choice of treatment should be made carefully.
© 2022. The Author(s) under exclusive licence to The Japan Esophageal Society.

Entities:  

Keywords:  Cervical esophageal cancer; Functional laryngeal preservation; Laryngeal preservation; Multicenter study

Mesh:

Year:  2022        PMID: 35525856     DOI: 10.1007/s10388-022-00921-w

Source DB:  PubMed          Journal:  Esophagus        ISSN: 1612-9059            Impact factor:   3.671


  6 in total

1.  Pharyngogastric anastomosis after oesophago-pharyngectomy for carcinoma of the hypopharynx and cervical oesophagus.

Authors:  G B ONG; T C LEE
Journal:  Br J Surg       Date:  1960-09       Impact factor: 6.939

Review 2.  Cervical Esophageal Cancers: Challenges and Opportunities.

Authors:  Michael Buckstein; Jerry Liu
Journal:  Curr Oncol Rep       Date:  2019-04-04       Impact factor: 5.075

3.  Comparison of curative surgery and definitive chemoradiotherapy as initial treatment for patients with cervical esophageal cancer.

Authors:  Katsushi Takebayashi; Yasuhiro Tsubosa; Satoru Matsuda; Keisuke Kawamorita; Masahiro Niihara; Takahiro Tsushima; Tomoya Yokota; Hiroshi Sato; Yusuke Onozawa; Hirofumi Ogawa; Tomoyuki Kamijo; Tetsuro Onitsuka; Masahiro Nakagawa; Hirofumi Yasui
Journal:  Dis Esophagus       Date:  2017-02-01       Impact factor: 3.429

4.  Surgical management of cervical esophageal carcinoma with larynx preservation and reconstruction.

Authors:  Fenglin Sun; Xuezhong Li; Dapeng Lei; Tong Jin; Dayu Liu; Hui Zhao; Qiuan Yang; Guojun Li; Xinliang Pan
Journal:  Int J Clin Exp Med       Date:  2014-09-15

5.  Outcomes and prognostic factors for patients with cervical esophageal cancer undergoing definitive radiotherapy or chemoradiotherapy.

Authors:  Xin-Xin Du; Rong Yu; Zhen-Fei Wang; De-Cheng Du; Qiao-Yun Liu; Run-Mei Wang; Shi-Rong Kang; Hao Yang
Journal:  Bosn J Basic Med Sci       Date:  2019-05-20       Impact factor: 3.363

6.  Comprehensive registry of esophageal cancer in Japan, 2012.

Authors:  Yuji Tachimori; Soji Ozawa; Hodaka Numasaki; Ryu Ishihara; Hisahiro Matsubara; Kei Muro; Tsuneo Oyama; Yasushi Toh; Harushi Udagawa; Takashi Uno
Journal:  Esophagus       Date:  2019-05-16       Impact factor: 4.230

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.